2023 Care Utilization Trends and the Impact on Service Line Planning, Patient Engagement and Care Redesign

March 7, 2023
This activity will address the changing economic, demographic and payor landscape creating the imperative for health system operating model change, including across key service lines. This segment will additionally provide the framework for health system performance optimization and agility at the service line level to achieve maximum clinical, operational, and patient experience in economically uncertain times. 
 
For more than 25 years, the 340B Drug Pricing Program has provided financial help to hospitals and other covered entities serving vulnerable communities to manage rising prescription drug costs. This session will cover recent trends related to reporting requirements, reimbursement rates and pricing, and other key challenges impacting health system pharmacies' ability to optimize the 340B Drug Discount. The discussion will also touch on shifts in site of care, legislative and regulatory activity, manufacturer threats to contract pharmacy and the outlook for 340B overall. 

Target Audience

  • Healthcare Executives
  • Nurses
  • Pharmacists
  • Supply Chain Professionals

Learning Objectives

At the conclusion of this activity, participants should be able to:

  1. Identify unprecedented emerging market trends in the changing healthcare landscape.
  2. Explain consumer expectations in health care access and care delivery in order to develop successful strategies for patient engagement
  3. Describe Care Shifts and the implications on resourcing to anticipate the changing landscape of Inpatient Care.
  4. Outline key challenges impacting health system pharmacies' ability to optimize the 340B Drug Discount.
  5. Discuss new policy impacting member participation and accountability to the 340B drug program.

At the conclusion of this activity, pharmacists should be able to:

  1. Outline key challenges impacting health system pharmacies' ability to optimize the 340B Drug Discount.
  2. Discuss new policy impacting member participation and accountability to the 340B drug program.
Course summary
Available credit: 
  • 1.50 ACHE
  • 1.50 ACPE Pharmacist
  • 1.50 ANCC
  • 1.50 General CE - Attendance
Course opens: 
02/16/2023
Course expires: 
04/24/2023
Event starts: 
03/07/2023 - 2:30pm CST
Event ends: 
03/07/2023 - 4:00pm CST
Part of: 
Southern Strategic Sourcing Partners (S3P) 2023 All Member Clinical Supply Conference
Add to calendar: 

Faculty

Planning Committee

Kristin Allen, MSN
Sr. Director, Strategic Sourcing Partnerships & Programs
Vizient, Inc.
 
Rosa Byrd, MSN, RN
Director, Cardiac Cath Lab
Forrest Health
 
Michael McLemore, BSN, RN
Network Director
Vizient, Inc.
 
Mitch Brown, PharmD
Pharmacy Executive Director
Vizient Inc.
 
 

Faculty

Jeff Moser, MS
Principal, Sg2
Vizient, Inc.
 
Greg Medley, PharmD
Pharmacy Sr. Director
Vizient, Inc.
 
 Disclosure
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
 
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
 
FDA Off-Label Use
 
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
 
Disclosure Statements
 
Absence of Relevant Financial Relationships
 
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 

Disclaimer

The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.

Joint Accreditation Statement

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
 
 

Designation Statement(s) 

Nurses (CNE)

This activity is designated for 1.50 contacts hours.

Pharmacists (CPE)

Vizient, Inc. designates this live activity for a maximum of 1.50 contact hours for Pharmacists. 

Universal Activity Number:  JA0006103-0000-23-041-L04-P

Healthcare Executives (ACHE)

By attending Southern Strategic Sourcing Partners (S3P) 2023 All Member Clinical Supply Conference offered by Vizient, Inc. participants may earn up to 1.50 ACHE Qualified Education Hours toward initial certification or recertification of the Fellow of the American College of Healthcare Executives (FACHE) designation.

Participants in this program who wish to have it considered for ACHE Qualified Education hours should list their attendance when they apply to the American College of Healthcare Executives for advancement or recertification. Participants are responsible for maintaining a record of their ACHE Qualified Education hours. To self-report, participants should log into their MyACHE account and select ACHE Qualified Education Credit.

Other Healthcare Professionals (General CE Credit)

Vizient, Inc. will award a maximum of 1.50 contact hours to all other healthcare professionals who successfully complete the activity. These individuals will receive a Certificate of Participation indicating the maximum credits available.

Many state licensing boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

 

Available Credit

  • 1.50 ACHE
  • 1.50 ACPE Pharmacist
  • 1.50 ANCC
  • 1.50 General CE - Attendance
Please login or register to take this course.

 

Select the Obtain Credit button to access the activity evaluation.